Cristiane Bergerot, Director of the Department of Psycho-Oncology at CETTRO Cancer Research Hospital, shared a post on X:
“Excited that our FKSI-23 measure, designed to assess HRQOL in patients with localized and advanced RCC, is available on the FACIT website.”
Shilpa Gupta, Director of Genitourinary Oncology at Cleveland Clinic, shared this post, adding:
“Congrats, Cristiane Bergerot, on leading the way with HRQIL relevant in the current therapeutic era in Kidney cancer! Congrats to mentors Sumanta Pal and Tom Powles.”
More posts featuring Cristiane Bergerot and Shilpa Gupta.